Genes associated with cell immune functions were enriched in these pathways, such as COPS5, GSTM5, and TPI1 (Figure 4B; Table S2), indicating the critical role of 5hmC modifications in immune response in lung cancer treatment. The gene discussed is TPI1; the disease is lung cancer.